In the future, you could be your very own fountain of youth – or at least your own skin repair reservoir. In a proof-of-concept study, researchers from North Carolina State University have shown that exosomes harvested from human skin cells are more effective at repairing sun-damaged skin cells in mice than popular retinol or stem cell-based treatments currently in use. Additionally, the nanometer-sized exosomes can be delivered to the target cells via needle-free injections.
Exosomes are tiny sacs (30 – 150 nanometers across) that are excreted and taken up by cells. They can transfer DNA, RNA or proteins from cell to cell, affecting the function of the recipient cell. In the regenerative medicine field, exosomes are being tested as carriers of stem cell-based treatments for diseases ranging from heart disease to respiratory disorders.
“Think of an exosome as an envelope with instructions inside – like one cell mailing a letter to another cell and telling it what to do,” says Ke Cheng, professor of molecular biomedical sciences at NC State, professor in the NC State/UNC-Chapel Hill Joint Department of Biomedical Engineering and corresponding author of a paper describing the work. “In this case, the envelope contains microRNA, non-coding RNA that instructs the recipient cell to produce more collagen.”
To test whether exosomes could be effective for skin repair, Cheng and his team first grew and harvested exosomes from skin cells. They used commercially available human dermal fibroblast cells, expanding them in a suspension culture that allowed the cells to adhere to one another, forming spheroids. The spheroids then excreted exosomes into the media.
“These 3D structures generate more procollagen – more potent exosomes – than you get with 2D cell expansion,” says Cheng.
In a photoaged, nude mouse model, Cheng tested the 3D spheroid-grown exosomes against three other treatments: retinoid cream; 2D-grown exosomes; and bone marrow derived mesenchymal stem cells (MSCs) exosomes, a popular stem cell-based anti-aging treatment currently in use. The team compared improvements in skin thickness and collagen production after treatment. They found that skin thickness in 3D exosome treated mice was 20% better than in the untreated and 5% better than in the MSC-treated mouse. Additionally, they found 30% more collagen production in skin treated with the 3D exosomes than in the MSC treated skin, which was the second most effective treatment.
“I think this study shows the potential for 3D exosomes to be used in anti-aging skin treatments,” says Cheng. “There are two major benefits to exosome treatments over conventional treatments: one, you can use donor skin cells from anyone to grow and harvest these exosomes – they aren’t cells, so you don’t run the risk of rejection. And two, the treatment can be administered without needles – exosomes are small enough to be able to penetrate the skin via pressure, or jet injection methods.
“Our hope is that eventually people may be able to ‘bank’ skin samples and come back to them, or use donor exosome treatments that they can administer themselves. We believe that this work is an important step toward potentiating future human clinical trials in the prevention and treatment of cutaneous aging.”
The Latest on: Exosome treatments
via Google News
The Latest on: Exosome treatments
- The roles of exosomal miRNAs and lncRNAs in lung diseaseson November 13, 2019 at 11:18 pm
With further exploration of exosome content, a more accurate molecular mechanism involved in the process ... which has shed light on the discovery of novel diagnostic methods and treatments for these ...
- Aruna Bio Appoints Dr. Renee Boerner as Vice President of Regulatory Affairson November 13, 2019 at 4:17 pm
Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the appointment of Renee Boerner, PhD, as Vice President of Regulatory ...
- Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conferenceon November 8, 2019 at 4:07 pm
Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief ...
- Sienna & VivaZome Evaluate EXO-NET for Exosome Therapeuticson November 7, 2019 at 5:48 pm
VivaZome is developing exosome-based therapies for debilitating and/or life-threatening diseases Initial targeted therapy is for the treatment for Critical Limb Ischaemia (CLI) - 4 million patients ...
- Spherical exosomes may deliver what an injured kidney needson November 7, 2019 at 8:15 am
Like the construction workers, scientists suspect these spheres, called exosomes, are there to repair damage and ... system for an injury with an increasing incidence and without good treatment.
- Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndromeon November 7, 2019 at 4:26 am
The levels of Ang-2, VEGF in medium or lung tissue and ALB, HB in serum exosomes were measured by ELISA assay kits following the manufacturer’s instructions (R&D Systems, USA). After different ...
- Study: Spherical exosomes could help in treating acute kidney injuryon November 5, 2019 at 8:36 pm
Like the construction workers, scientists suspect these spheres, called exosomes, are there to repair damage and restore function ... this apparent endogenous recovery system for an injury with an ...
- Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q2 2020 Results - Earnings Call Transcripton November 4, 2019 at 4:24 pm
At Aethlon, we are continuing to develop our proprietary device, the Hemopurifier, which is the first in class therapeutic device that’s designed for the single use depletion of circulating viruses ...
- Crossing Over From Supplier To Sponsoron November 1, 2019 at 10:54 am
Exosomes may also have a unique therapeutic advantage because they do not seem to trigger an immune response, making them a potentially safer approach to treatment. Those were all compelling reasons ...
- Exosomes Market Size, Share, Worldwide Players, Regional Analysis, Segments, Future Trends and Forecast to 2027on October 29, 2019 at 10:55 pm
Exosome therapy is the new treatment accept by the doctor and it is used to early stage of cancer detection. Exosome therapy is important then stem cell due to their unique ability to function as a ...
via Bing News